Online Trial Tracker - Larvol Sigma

Ixempra (ixabepilone) / Otsuka, R-Pharm, BMS, Allarity Therap

Welcome, Profile Billing Logout

1 Trials

Active Trials Industry lead sponsorIndustry collaborator

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Ixempra (ixabepilone) / Otsuka, R-Pharm, Allarity Therap

NCT04796324 / 2020-004610-35: Anti-tumor Effect of Ixabepilone in Metastatic Breast Cancer (mBC) Selected by the Ixabepilone DRP.

Recruiting

Europe

Ixabepilone Injection

Allarity Therapeutics, Allarity Therapeutics

Metastatic Breast Cancer

09/24

11/25

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites